MARTHA ST JOHN: Open Payments
NPI 1073534921 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 62 payments from 17 companies in 2025. Trend: 2023 $1,023 · 2024 $1,242 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $276 |
| ABBVIE INC. | 11 | $216 |
| Axsome Therapeutics, Inc. | 5 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Neurocrine BioSciences, Inc. | 4 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Noven Therapeutics, LLC | 4 | $80 |
| Corium, LLC | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Neos Therapeutics, LP | 3 | $54 |
Products named: CAPLYTA, VRAYLAR, Auvelity, TRINTELLIX, INGREZZA, COBENFY, Xelstrym, Azstarys.
Industry payments across TX — which companies pay providers there.
